25 XP   0   0   10

Apeloa Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Apeloa together

PenkeI guess you are interested in Apeloa Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Apeloa Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Apeloa Pharmaceutical Co Ltd

I send you an email if I find something interesting about Apeloa Pharmaceutical Co Ltd.

Quick analysis of Apeloa (30 sec.)










What can you expect buying and holding a share of Apeloa? (30 sec.)

How much money do you get?

How much money do you get?
¥0.09
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.29
Expected worth in 1 year
¥5.89
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥1.22
Return On Investment
9.5%

For what price can you sell your share?

Current Price per Share
¥12.90
Expected price per share
¥10.66 - ¥14.44
How sure are you?
50%

1. Valuation of Apeloa (5 min.)




Live pricePrice per Share (EOD)

¥12.90

Intrinsic Value Per Share

¥2.03 - ¥5.76

Total Value Per Share

¥7.31 - ¥11.05

2. Growth of Apeloa (5 min.)




Is Apeloa growing?

Current yearPrevious yearGrowGrow %
How rich?$861m$722.4m$99.1m12.1%

How much money is Apeloa making?

Current yearPrevious yearGrowGrow %
Making money$36.4m$34.1m$2.2m6.3%
Net Profit Margin9.3%9.2%--

How much money comes from the company's main activities?

3. Financial Health of Apeloa (5 min.)




What can you expect buying and holding a share of Apeloa? (5 min.)

Welcome investor! Apeloa's management wants to use your money to grow the business. In return you get a share of Apeloa.

What can you expect buying and holding a share of Apeloa?

First you should know what it really means to hold a share of Apeloa. And how you can make/lose money.

Speculation

The Price per Share of Apeloa is ¥12.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Apeloa.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Apeloa, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.29. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.15 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Apeloa.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.2%0.030.2%0.030.2%0.030.2%0.020.1%
Usd Book Value Change Per Share0.020.2%0.020.2%0.010.1%0.020.1%0.010.1%
Usd Dividend Per Share0.000.0%0.020.2%0.010.1%0.020.1%0.010.1%
Usd Total Gains Per Share0.030.2%0.040.3%0.020.2%0.030.3%0.020.2%
Usd Price Per Share2.13-2.50-3.10-2.97-2.00-
Price to Earnings Ratio22.23-21.02-27.77-30.13-33.59-
Price-to-Total Gains Ratio83.68-65.16--47.51-64.00-68.41-
Price to Book Ratio2.91-3.60-5.07-5.38-4.41-
Price-to-Total Gains Ratio83.68-65.16--47.51-64.00-68.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.78278
Number of shares560
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.020.02
Usd Total Gains Per Share0.040.03
Gains per Quarter (560 shares)23.6718.42
Gains per Year (560 shares)94.6673.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1484785363864
296931807276138
3144140275107114212
4192187370143152286
5240234465179190360
6288280560215228434
7336327655250266508
8384374750286303582
9432420845322341656
10480467940358379730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%83.00.01.098.8%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%37.03.00.092.5%75.09.00.089.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%75.00.09.089.3%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%38.02.00.095.0%79.05.00.094.0%

Fundamentals of Apeloa

About Apeloa Pharmaceutical Co Ltd

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. The company was founded in 1989 and is based in Dongyang, China.

Fundamental data was last updated by Penke on 2024-04-13 18:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Apeloa Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Apeloa earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Apeloa to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.9% means that ¥0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 6.9%. The company is making a profit. +1
  • The TTM is 9.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.9%TTM9.3%-2.4%
TTM9.3%YOY9.2%+0.1%
TTM9.3%5Y9.4%-0.2%
5Y9.4%10Y7.5%+1.9%
1.1.2. Return on Assets

Shows how efficient Apeloa is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Apeloa to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.6% Return on Assets means that Apeloa generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM2.1%-0.5%
TTM2.1%YOY2.3%-0.2%
TTM2.1%5Y2.4%-0.3%
5Y2.4%10Y1.9%+0.6%
1.1.3. Return on Equity

Shows how efficient Apeloa is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Apeloa to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.3% Return on Equity means Apeloa generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 3.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM4.5%-1.2%
TTM4.5%YOY4.7%-0.3%
TTM4.5%5Y4.6%-0.1%
5Y4.6%10Y3.7%+0.9%

1.2. Operating Efficiency of Apeloa Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Apeloa is operating .

  • Measures how much profit Apeloa makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Apeloa to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM9.0%-9.0%
TTM9.0%YOY8.7%+0.3%
TTM9.0%5Y9.8%-0.8%
5Y9.8%10Y5.2%+4.6%
1.2.2. Operating Ratio

Measures how efficient Apeloa is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.70 means that the operating costs are ¥1.70 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 1.697. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.634. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.697TTM1.634+0.063
TTM1.634YOY1.659-0.025
TTM1.6345Y1.616+0.018
5Y1.61610Y1.188+0.429

1.3. Liquidity of Apeloa Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Apeloa is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.33 means the company has ¥1.33 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 1.327. The company is just able to pay all its short-term debts.
  • The TTM is 1.309. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.327TTM1.309+0.017
TTM1.309YOY1.353-0.043
TTM1.3095Y1.471-0.162
5Y1.47110Y0.803+0.668
1.3.2. Quick Ratio

Measures if Apeloa is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Apeloa to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.27 means the company can pay off ¥0.27 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 0.269. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.334. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.269TTM0.334-0.065
TTM0.334YOY0.404-0.071
TTM0.3345Y0.463-0.129
5Y0.46310Y0.447+0.016

1.4. Solvency of Apeloa Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Apeloa assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Apeloa to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.51 means that Apeloa assets are financed with 51.2% credit (debt) and the remaining percentage (100% - 51.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 0.512. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.531. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.512TTM0.531-0.019
TTM0.531YOY0.518+0.013
TTM0.5315Y0.471+0.060
5Y0.47110Y0.496-0.025
1.4.2. Debt to Equity Ratio

Measures if Apeloa is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Apeloa to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 105.1% means that company has ¥1.05 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Apeloa Pharmaceutical Co Ltd:

  • The MRQ is 1.051. The company is able to pay all its debts with equity. +1
  • The TTM is 1.138. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.051TTM1.138-0.087
TTM1.138YOY1.081+0.057
TTM1.1385Y0.908+0.230
5Y0.90810Y1.007-0.099

2. Market Valuation of Apeloa Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Apeloa generates.

  • Above 15 is considered overpriced but always compare Apeloa to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 22.23 means the investor is paying ¥22.23 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Apeloa Pharmaceutical Co Ltd:

  • The EOD is 18.631. Based on the earnings, the company is fair priced.
  • The MRQ is 22.228. Based on the earnings, the company is fair priced.
  • The TTM is 21.019. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD18.631MRQ22.228-3.596
MRQ22.228TTM21.019+1.208
TTM21.019YOY27.767-6.748
TTM21.0195Y30.129-9.110
5Y30.12910Y33.587-3.458
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Apeloa Pharmaceutical Co Ltd:

  • The EOD is -124.213. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -148.189. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 0.463. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-124.213MRQ-148.189+23.976
MRQ-148.189TTM0.463-148.652
TTM0.463YOY290.352-289.889
TTM0.4635Y64.157-63.694
5Y64.15710Y35.912+28.244
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Apeloa is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Apeloa Pharmaceutical Co Ltd:

  • The EOD is 2.440. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.911. Based on the equity, the company is underpriced. +1
  • The TTM is 3.604. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.440MRQ2.911-0.471
MRQ2.911TTM3.604-0.693
TTM3.604YOY5.068-1.464
TTM3.6045Y5.379-1.775
5Y5.37910Y4.413+0.965
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Apeloa Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1780.151+18%0.097+83%0.123+45%0.093+92%
Book Value Per Share--5.2875.044+5%4.436+19%4.021+31%3.124+69%
Current Ratio--1.3271.309+1%1.353-2%1.471-10%0.803+65%
Debt To Asset Ratio--0.5120.531-4%0.518-1%0.471+9%0.496+3%
Debt To Equity Ratio--1.0511.138-8%1.081-3%0.908+16%1.007+4%
Dividend Per Share--0.0060.155-96%0.077-92%0.116-95%0.086-93%
Eps--0.1730.224-23%0.210-18%0.185-7%0.123+41%
Free Cash Flow Per Share---0.0260.085-131%0.173-115%0.133-119%0.095-127%
Free Cash Flow To Equity Per Share---0.0260.019-234%0.132-120%0.089-129%0.074-135%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.760--------
Intrinsic Value_10Y_min--2.028--------
Intrinsic Value_1Y_max--0.408--------
Intrinsic Value_1Y_min--0.301--------
Intrinsic Value_3Y_max--1.355--------
Intrinsic Value_3Y_min--0.826--------
Intrinsic Value_5Y_max--2.458--------
Intrinsic Value_5Y_min--1.259--------
Market Cap15202908825.600-19%18137476541.88021337167822.660-15%26475530247.780-31%25307313133.330-28%17069984309.385+6%
Net Profit Margin--0.0690.093-26%0.092-25%0.094-27%0.075-9%
Operating Margin---0.090-100%0.087-100%0.098-100%0.052-100%
Operating Ratio--1.6971.634+4%1.659+2%1.616+5%1.188+43%
Pb Ratio2.440-19%2.9113.604-19%5.068-43%5.379-46%4.413-34%
Pe Ratio18.631-19%22.22821.019+6%27.767-20%30.129-26%33.587-34%
Price Per Share12.900-19%15.39018.105-15%22.465-31%21.474-28%14.484+6%
Price To Free Cash Flow Ratio-124.213+16%-148.1890.463-32132%290.352-151%64.157-331%35.912-513%
Price To Total Gains Ratio70.142-19%83.68265.162+28%-47.512+157%63.998+31%68.415+22%
Quick Ratio--0.2690.334-19%0.404-34%0.463-42%0.447-40%
Return On Assets--0.0160.021-23%0.023-29%0.024-34%0.019-14%
Return On Equity--0.0330.045-27%0.047-31%0.046-29%0.037-11%
Total Gains Per Share--0.1840.306-40%0.174+5%0.238-23%0.178+3%
Usd Book Value--861043656.520821587416.988+5%722466425.560+19%654845323.809+31%508746739.817+69%
Usd Book Value Change Per Share--0.0250.021+18%0.013+83%0.017+45%0.013+92%
Usd Book Value Per Share--0.7310.697+5%0.613+19%0.556+31%0.432+69%
Usd Dividend Per Share--0.0010.021-96%0.011-92%0.016-95%0.012-93%
Usd Eps--0.0240.031-23%0.029-18%0.026-7%0.017+41%
Usd Free Cash Flow---4228706.13613850958.893-131%28227330.746-115%21740191.456-119%14659005.032-129%
Usd Free Cash Flow Per Share---0.0040.012-131%0.024-115%0.018-119%0.013-127%
Usd Free Cash Flow To Equity Per Share---0.0040.003-234%0.018-120%0.012-129%0.010-135%
Usd Market Cap2101041999.698-19%2506599258.0882948796593.092-15%3658918280.243-31%3497470675.026-28%2359071831.557+6%
Usd Price Per Share1.783-19%2.1272.502-15%3.105-31%2.968-28%2.002+6%
Usd Profit--28192337.98836462022.594-23%34175950.493-18%30198050.319-7%20006682.687+41%
Usd Revenue--411017418.806396432309.731+4%364326480.781+13%318219804.427+29%246430804.084+67%
Usd Total Gains Per Share--0.0250.042-40%0.024+5%0.033-23%0.025+3%
 EOD+3 -5MRQTTM+13 -22YOY+15 -205Y+11 -2410Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Apeloa Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.631
Price to Book Ratio (EOD)Between0-12.440
Net Profit Margin (MRQ)Greater than00.069
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.269
Current Ratio (MRQ)Greater than11.327
Debt to Asset Ratio (MRQ)Less than10.512
Debt to Equity Ratio (MRQ)Less than11.051
Return on Equity (MRQ)Greater than0.150.033
Return on Assets (MRQ)Greater than0.050.016
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Apeloa Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.017
Ma 20Greater thanMa 5012.895
Ma 50Greater thanMa 10013.168
Ma 100Greater thanMa 20014.151
OpenGreater thanClose12.870
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Selling General Administrative  129,533142,071271,604-233,52538,079440,085478,163-530,017-51,853



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets12,767,664
Total Liabilities6,537,247
Total Stockholder Equity6,222,729
 As reported
Total Liabilities 6,537,247
Total Stockholder Equity+ 6,222,729
Total Assets = 12,767,664

Assets

Total Assets12,767,664
Total Current Assets8,368,160
Long-term Assets4,399,504
Total Current Assets
Cash And Cash Equivalents 3,580,687
Net Receivables 1,695,033
Inventory 2,083,301
Other Current Assets 170,777
Total Current Assets  (as reported)8,368,160
Total Current Assets  (calculated)7,529,798
+/- 838,362
Long-term Assets
Property Plant Equipment 3,563,625
Goodwill 20,310
Intangible Assets 319,796
Long-term Assets Other 53,754
Long-term Assets  (as reported)4,399,504
Long-term Assets  (calculated)3,957,485
+/- 442,019

Liabilities & Shareholders' Equity

Total Current Liabilities6,307,728
Long-term Liabilities229,519
Total Stockholder Equity6,222,729
Total Current Liabilities
Short Long Term Debt 807,796
Accounts payable 4,126,734
Other Current Liabilities 416,265
Total Current Liabilities  (as reported)6,307,728
Total Current Liabilities  (calculated)5,350,795
+/- 956,933
Long-term Liabilities
Long term Debt 18,715
Capital Lease Obligations Min Short Term Debt4,473
Long-term Liabilities  (as reported)229,519
Long-term Liabilities  (calculated)23,187
+/- 206,332
Total Stockholder Equity
Retained Earnings 4,520,035
Total Stockholder Equity (as reported)6,222,729
Total Stockholder Equity (calculated)4,520,035
+/- 1,702,694
Other
Capital Stock1,178,523
Common Stock Shares Outstanding 1,178,523
Net Invested Capital 7,049,240
Net Working Capital 2,060,433
Property Plant and Equipment Gross 6,973,099



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302004-12-312004-09-302004-06-302003-12-312003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
535,114
546,583
465,545
587,377
694,357
709,532
747,033
689,278
742,907
781,344
863,065
925,994
989,583
1,114,475
967,126
1,073,718
1,144,870
1,187,615
1,214,584
1,142,568
1,284,450
1,274,722
1,532,895
1,460,693
1,614,126
1,608,532
1,704,325
1,681,466
1,741,115
1,841,958
1,805,696
1,797,942
1,749,690
1,760,963
1,886,379
1,877,602
1,844,574
1,855,288
1,900,154
1,868,147
2,061,752
2,053,958
2,125,671
2,065,965
4,107,221
4,497,656
4,328,987
4,441,945
4,662,256
4,644,500
4,826,613
5,045,323
5,061,812
5,151,504
5,332,073
5,467,354
5,394,939
5,568,373
5,453,097
5,467,574
5,618,957
5,840,157
5,650,113
5,662,625
5,691,124
5,844,573
5,699,530
5,804,986
5,750,766
5,718,776
6,023,244
6,323,047
6,522,586
7,070,877
7,664,445
7,727,974
7,494,788
8,054,954
8,435,812
8,786,553
9,163,330
10,019,158
10,333,215
11,157,719
12,016,599
12,683,653
12,674,775
12,619,686
12,767,664
12,767,66412,619,68612,674,77512,683,65312,016,59911,157,71910,333,21510,019,1589,163,3308,786,5538,435,8128,054,9547,494,7887,727,9747,664,4457,070,8776,522,5866,323,0476,023,2445,718,7765,750,7665,804,9865,699,5305,844,5735,691,1245,662,6255,650,1135,840,1575,618,9575,467,5745,453,0975,568,3735,394,9395,467,3545,332,0735,151,5045,061,8125,045,3234,826,6134,644,5004,662,2564,441,9454,328,9874,497,6564,107,2212,065,9652,125,6712,053,9582,061,7521,868,1471,900,1541,855,2881,844,5741,877,6021,886,3791,760,9631,749,6901,797,9421,805,6961,841,9581,741,1151,681,4661,704,3251,608,5321,614,1261,460,6931,532,8951,274,7221,284,4501,142,5681,214,5841,187,6151,144,8701,073,718967,1261,114,475989,583925,994863,065781,344742,907689,278747,033709,532694,357587,377465,545546,583535,114
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,095,609
3,074,537
3,105,796
3,438,478
3,771,769
3,957,973
4,529,509
5,115,285
5,207,793
4,917,397
5,468,223
5,656,704
5,827,752
5,781,910
6,669,575
6,669,575
7,285,271
7,781,108
8,502,757
8,391,676
8,264,143
8,368,160
8,368,1608,264,1438,391,6768,502,7577,781,1087,285,2716,669,5756,669,5755,781,9105,827,7525,656,7045,468,2234,917,3975,207,7935,115,2854,529,5093,957,9733,771,7693,438,4783,105,7963,074,5373,095,6090000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
721,615
644,023
638,903
768,981
893,092
1,035,809
1,371,035
1,916,682
2,422,254
2,194,231
2,683,061
2,642,765
2,698,856
2,610,011
2,988,413
2,672,535
3,325,482
3,552,858
3,623,206
3,810,977
3,705,020
3,580,687
3,580,6873,705,0203,810,9773,623,2063,552,8583,325,4822,672,5352,988,4132,610,0112,698,8562,642,7652,683,0612,194,2312,422,2541,916,6821,371,0351,035,809893,092768,981638,903644,023721,6150000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101,400
42,450
100,000
310,000
463,858
436,662
336,662
138,841
116,216
40,606
21,751
17,022
14,892
10,850
0
0
90
0
0
0
0
0000900010,85014,89217,02221,75140,606116,216138,841336,662436,662463,858310,000100,00042,450101,40000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
75,605
71,167
67,517
62,149
0
113,445
136,386
106,227
0
151,414
149,885
142,476
123,500
150,055
142,466
185,122
165,456
208,091
168,009
203,193
218,163
232,029
228,409
250,246
174,248
167,943
190,794
164,491
161,363
193,290
240,857
234,644
239,273
225,203
274,076
248,182
196,841
239,878
203,706
220,255
274,148
318,376
313,196
281,860
706,791
784,688
856,484
760,672
801,590
830,233
914,216
911,188
830,172
897,029
868,846
862,518
824,288
865,366
938,789
1,070,576
1,201,365
1,274,050
1,176,881
1,278,027
1,386,808
1,433,368
1,505,285
1,302,426
1,242,804
1,150,021
1,104,690
1,122,068
1,256,725
1,408,352
1,651,677
1,376,964
1,317,628
1,422,786
1,655,619
1,586,822
1,626,349
2,229,471
2,229,471
1,782,671
2,156,282
2,581,994
2,284,916
1,994,863
1,695,033
1,695,0331,994,8632,284,9162,581,9942,156,2821,782,6712,229,4712,229,4711,626,3491,586,8221,655,6191,422,7861,317,6281,376,9641,651,6771,408,3521,256,7251,122,0681,104,6901,150,0211,242,8041,302,4261,505,2851,433,3681,386,8081,278,0271,176,8811,274,0501,201,3651,070,576938,789865,366824,288862,518868,846897,029830,172911,188914,216830,233801,590760,672856,484784,688706,791281,860313,196318,376274,148220,255203,706239,878196,841248,182274,076225,203239,273234,644240,857193,290161,363164,491190,794167,943174,248250,246228,409232,029218,163203,193168,009208,091165,456185,122142,466150,055123,500142,476149,885151,4140106,227136,386113,445062,14967,51771,16775,605
       Other Current Assets 
3,642
9,713
4,418
19,782
248,165
2,881
12,597
7,082
0
5,818
5,329
4,442
6,551
11,487
1,020
2,134
29,852
1,359
21,129
3,075
7,286
1,270
1,098
6,522
53,481
46,474
31,778
57,047
56,915
29,824
26,093
26,758
48,787
28,597
34,005
41,407
67,428
20,753
37,164
50,392
39,317
35,842
44,920
64,805
54,335
118,379
150,549
203,022
137,729
151,493
170,162
177,178
110,304
142,278
170,742
166,192
124,112
170,614
170,211
160,875
193,934
219,514
171,305
170,872
205,104
219,876
228,040
232,526
182,550
47,685
52,430
71,291
199,545
272,747
245,777
242,007
187,098
271,330
329,043
378,646
267,718
379,737
379,737
481,206
249,501
504,121
398,612
530,764
170,777
170,777530,764398,612504,121249,501481,206379,737379,737267,718378,646329,043271,330187,098242,007245,777272,747199,54571,29152,43047,685182,550232,526228,040219,876205,104170,872171,305219,514193,934160,875170,211170,614124,112166,192170,742142,278110,304177,178170,162151,493137,729203,022150,549118,37954,33564,80544,92035,84239,31750,39237,16420,75367,42841,40734,00528,59748,78726,75826,09329,82456,91557,04731,77846,47453,4816,5221,0981,2707,2863,07521,1291,35929,8522,1341,02011,4876,5514,4425,3295,81807,08212,5972,881248,16519,7824,4189,7133,642
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,612,980
2,584,766
2,551,278
2,564,613
2,541,369
2,549,160
2,520,181
2,577,391
2,586,730
2,779,108
2,958,801
3,381,420
3,497,726
3,663,639
3,872,447
4,235,491
4,180,896
4,283,100
4,355,542
4,399,504
4,399,5044,355,5424,283,1004,180,8964,235,4913,872,4473,663,6393,497,7263,381,4202,958,8012,779,1082,586,7302,577,3912,520,1812,549,1602,541,3692,564,6132,551,2782,584,7662,612,980000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
244,010
243,401
241,898
317,481
0
341,514
341,385
324,399
0
343,866
347,656
382,848
386,027
533,027
562,860
568,196
609,601
589,935
591,704
592,756
603,922
600,702
599,625
608,613
693,981
564,875
792,485
657,882
994,633
721,530
1,019,187
759,459
988,477
749,062
976,851
779,884
1,034,593
830,831
1,052,128
853,680
1,157,553
874,069
1,147,570
894,335
1,938,741
1,552,353
1,911,104
1,546,562
2,135,302
1,702,186
1,769,472
1,888,099
2,139,400
2,101,049
2,159,387
2,205,266
2,305,994
2,248,667
2,265,542
2,263,941
2,340,153
2,306,698
2,312,651
2,275,972
2,286,760
2,218,597
2,172,140
2,142,316
2,123,250
2,071,137
2,031,511
2,019,137
2,017,820
1,976,907
1,971,614
1,955,285
1,981,214
2,003,219
2,133,530
2,257,549
2,682,849
2,950,260
2,950,260
3,132,810
3,405,875
3,399,807
3,457,367
3,510,326
3,563,625
3,563,6253,510,3263,457,3673,399,8073,405,8753,132,8102,950,2602,950,2602,682,8492,257,5492,133,5302,003,2191,981,2141,955,2851,971,6141,976,9072,017,8202,019,1372,031,5112,071,1372,123,2502,142,3162,172,1402,218,5972,286,7602,275,9722,312,6512,306,6982,340,1532,263,9412,265,5422,248,6672,305,9942,205,2662,159,3872,101,0492,139,4001,888,0991,769,4721,702,1862,135,3021,546,5621,911,1041,552,3531,938,741894,3351,147,570874,0691,157,553853,6801,052,128830,8311,034,593779,884976,851749,062988,477759,4591,019,187721,530994,633657,882792,485564,875693,981608,613599,625600,702603,922592,756591,704589,935609,601568,196562,860533,027386,027382,848347,656343,8660324,399341,385341,5140317,481241,898243,401244,010
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,310
20,310
27,663
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
29,504
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,310
20,31020,31020,31020,31020,31020,31020,31020,31020,31020,31020,31020,31020,31020,31020,31020,31020,31029,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50429,50427,66320,31020,3100000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
97,161
100,872
103,990
114,810
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000114,810103,990100,87297,1610000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
1,874
7,636
7,797
2,219
0
2,769
3,557
2,717
0
7,475
10,382
53,955
53,425
7,989
6,657
6,178
5,570
4,983
4,397
3,879
3,361
3,013
2,326
2,873
10,490
130,623
4,350
233,103
4,010
238,371
3,800
227,346
222,939
221,446
1,101
220,146
217,654
216,328
215,024
214,017
15,001
274,154
12,827
264,882
35,571
453,471
36,568
451,836
70,320
439,920
431,813
465,971
448,548
447,703
450,533
445,421
453,921
448,419
442,941
437,682
430,353
425,557
424,712
419,840
406,168
402,352
411,142
347,728
343,159
344,099
14,613
334,903
331,211
343,711
340,963
343,081
345,121
342,116
353,910
385,534
407,589
405,700
403,664
400,882
378,830
336,160
325,083
322,403
319,796
319,796322,403325,083336,160378,830400,882403,664405,700407,589385,534353,910342,116345,121343,081340,963343,711331,211334,90314,613344,099343,159347,728411,142402,352406,168419,840424,712425,557430,353437,682442,941448,419453,921445,421450,533447,703448,548465,971431,813439,92070,320451,83636,568453,47135,571264,88212,827274,15415,001214,017215,024216,328217,654220,1461,101221,446222,939227,3463,800238,3714,010233,1034,350130,62310,4902,8732,3263,0133,3613,8794,3974,9835,5706,1786,6577,98953,42553,95510,3827,47502,7173,5572,76902,2197,7977,6361,874
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,845
15,707
5,768
13,807
11,998
14,793
27,557
2,043,903
50,573
104,085
167,737
133,129
173,538
127,265
136,991
47,153
74,936
81,519
76,296
53,754
53,75476,29681,51974,93647,153136,991127,265173,538133,129167,737104,08550,5732,043,90327,55714,79311,99813,8075,76815,70716,845000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
223,582
231,456
153,953
327,672
427,586
432,791
469,147
402,878
0
474,442
534,237
571,446
633,150
743,398
582,580
679,285
732,945
774,560
789,187
708,721
828,680
829,704
790,047
720,261
864,019
853,747
940,314
908,775
973,002
1,070,152
1,027,745
1,010,706
954,905
962,027
1,083,578
1,074,621
1,036,001
1,044,501
1,104,621
1,077,517
1,255,083
1,246,146
1,313,578
1,245,646
2,741,646
2,834,904
2,608,136
2,677,468
2,804,427
2,681,297
2,782,212
2,540,803
2,755,867
2,797,486
2,893,279
3,073,183
2,978,148
3,113,832
2,985,275
2,941,417
3,002,463
3,160,797
2,968,679
2,948,153
2,641,129
2,727,769
2,539,164
2,556,915
2,406,481
2,263,021
2,527,799
2,676,919
2,754,599
3,148,219
3,661,503
3,524,200
3,104,113
3,447,175
3,778,066
3,920,087
4,103,324
4,807,046
5,340,797
5,970,723
6,497,373
6,924,825
6,904,886
6,599,155
6,537,247
6,537,2476,599,1556,904,8866,924,8256,497,3735,970,7235,340,7974,807,0464,103,3243,920,0873,778,0663,447,1753,104,1133,524,2003,661,5033,148,2192,754,5992,676,9192,527,7992,263,0212,406,4812,556,9152,539,1642,727,7692,641,1292,948,1532,968,6793,160,7973,002,4632,941,4172,985,2753,113,8322,978,1483,073,1832,893,2792,797,4862,755,8672,540,8032,782,2122,681,2972,804,4272,677,4682,608,1362,834,9042,741,6461,245,6461,313,5781,246,1461,255,0831,077,5171,104,6211,044,5011,036,0011,074,6211,083,578962,027954,9051,010,7061,027,7451,070,152973,002908,775940,314853,747864,019720,261790,047829,704828,680708,721789,187774,560732,945679,285582,580743,398633,150571,446534,237474,4420402,878469,147432,791427,586327,672153,953231,456223,582
   > Total Current Liabilities 
220,142
227,862
153,953
287,673
390,586
392,791
429,147
402,878
0
394,442
411,977
452,306
485,810
598,034
441,320
539,285
592,945
634,560
649,187
568,721
698,680
699,704
700,047
630,261
770,181
759,999
846,576
815,037
907,609
1,004,759
1,002,529
985,492
936,202
943,328
1,065,108
1,057,081
1,019,606
1,008,112
1,048,232
1,021,128
1,178,728
1,169,919
1,227,999
1,161,850
2,630,119
2,672,899
2,493,593
2,565,057
2,561,656
2,402,525
2,512,115
2,268,222
2,487,434
2,530,828
2,608,566
2,754,670
2,681,850
2,807,434
2,721,141
2,600,786
2,648,761
2,807,718
2,614,606
2,595,638
2,437,476
2,525,116
2,341,185
2,355,300
2,203,697
2,061,238
2,332,855
2,484,551
2,561,555
2,958,447
3,454,744
3,319,972
2,896,462
3,243,485
3,489,006
3,619,360
3,779,368
4,802,954
4,802,954
5,427,785
6,026,542
6,457,667
6,572,962
6,276,641
6,307,728
6,307,7286,276,6416,572,9626,457,6676,026,5425,427,7854,802,9544,802,9543,779,3683,619,3603,489,0063,243,4852,896,4623,319,9723,454,7442,958,4472,561,5552,484,5512,332,8552,061,2382,203,6972,355,3002,341,1852,525,1162,437,4762,595,6382,614,6062,807,7182,648,7612,600,7862,721,1412,807,4342,681,8502,754,6702,608,5662,530,8282,487,4342,268,2222,512,1152,402,5252,561,6562,565,0572,493,5932,672,8992,630,1191,161,8501,227,9991,169,9191,178,7281,021,1281,048,2321,008,1121,019,6061,057,0811,065,108943,328936,202985,4921,002,5291,004,759907,609815,037846,576759,999770,181630,261700,047699,704698,680568,721649,187634,560592,945539,285441,320598,034485,810452,306411,977394,4420402,878429,147392,791390,586287,673153,953227,862220,142
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
445,000
350,000
100,000
50,000
230,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000230,10050,000100,000350,000445,000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
445,000
350,000
100,000
50,000
230,100
230,100
230,100
330,279
535,334
438,093
383,607
332,474
501,226
530,527
562,490
562,811
673,953
841,096
786,007
807,796
807,796786,007841,096673,953562,811562,490530,527501,226332,474383,607438,093535,334330,279230,100230,100230,10050,000100,000350,000445,000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
41,989
36,685
24,203
70,671
0
83,460
135,620
77,145
0
102,496
130,581
111,590
98,556
174,207
105,953
108,435
158,011
140,310
163,858
151,845
225,161
181,753
188,159
202,789
322,499
367,320
374,737
323,270
335,171
325,353
392,457
359,300
407,851
364,114
504,340
451,689
405,020
420,971
441,926
419,209
510,189
436,299
464,568
448,805
1,168,230
1,383,402
1,314,750
1,263,321
1,109,700
1,096,712
1,213,508
1,278,644
1,339,601
1,453,590
1,475,657
1,401,618
1,332,952
1,270,488
1,200,420
1,171,486
1,151,885
1,207,094
1,097,788
996,845
933,858
1,128,561
1,047,872
1,079,404
1,113,348
1,112,261
1,449,163
1,840,436
1,865,931
2,248,969
2,695,652
2,505,657
1,928,663
2,061,449
2,469,423
2,595,735
2,622,539
3,617,703
3,617,703
4,025,799
4,310,571
4,731,829
4,515,387
4,229,757
4,126,734
4,126,7344,229,7574,515,3874,731,8294,310,5714,025,7993,617,7033,617,7032,622,5392,595,7352,469,4232,061,4491,928,6632,505,6572,695,6522,248,9691,865,9311,840,4361,449,1631,112,2611,113,3481,079,4041,047,8721,128,561933,858996,8451,097,7881,207,0941,151,8851,171,4861,200,4201,270,4881,332,9521,401,6181,475,6571,453,5901,339,6011,278,6441,213,5081,096,7121,109,7001,263,3211,314,7501,383,4021,168,230448,805464,568436,299510,189419,209441,926420,971405,020451,689504,340364,114407,851359,300392,457325,353335,171323,270374,737367,320322,499202,789188,159181,753225,161151,845163,858140,310158,011108,435105,953174,20798,556111,590130,581102,496077,145135,62083,460070,67124,20336,68541,989
       Other Current Liabilities 
91,253
74,167
13,740
62,792
390,586
90,121
80,817
61,023
0
84,236
78,186
90,506
76,044
71,617
95,657
89,640
101,724
111,040
100,622
112,573
90,458
62,741
46,678
50,262
78,472
50,469
109,629
81,557
102,228
99,196
132,362
115,982
108,141
97,251
97,956
108,929
118,873
104,181
89,333
106,171
117,022
110,782
144,920
125,774
219,249
223,959
221,112
218,686
246,010
174,246
175,461
198,666
389,068
234,719
281,244
348,728
315,761
254,956
358,446
345,170
380,776
279,524
357,718
444,694
415,609
398,798
408,413
378,592
360,877
431,285
432,132
418,556
464,185
408,695
375,180
432,751
388,124
571,314
452,247
502,531
588,764
485,313
485,313
667,880
941,290
921,583
1,022,715
1,053,927
416,265
416,2651,053,9271,022,715921,583941,290667,880485,313485,313588,764502,531452,247571,314388,124432,751375,180408,695464,185418,556432,132431,285360,877378,592408,413398,798415,609444,694357,718279,524380,776345,170358,446254,956315,761348,728281,244234,719389,068198,666175,461174,246246,010218,686221,112223,959219,249125,774144,920110,782117,022106,17189,333104,181118,873108,92997,95697,251108,141115,982132,36299,196102,22881,557109,62950,46978,47250,26246,67862,74190,458112,573100,622111,040101,72489,64095,65771,61776,04490,50678,18684,236061,02380,81790,121390,58662,79213,74074,16791,253
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
201,784
194,943
192,367
193,044
189,772
206,759
204,228
207,651
203,690
289,060
300,727
323,956
526,055
537,843
542,939
470,831
467,158
331,924
322,514
229,519
229,519322,514331,924467,158470,831542,939537,843526,055323,956300,727289,060203,690207,651204,228206,759189,772193,044192,367194,943201,784000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-445,000
-350,000
-100,000
-50,000
-230,100
0
0
0
0
0
0
22,947
22,667
21,179
19,717
15,813
15,408
14,845
8,900
4,473
4,4738,90014,84515,40815,81319,71721,17922,66722,947000000-230,100-50,000-100,000-350,000-445,000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
72,000
0
72,000
0
72,000
0
0
0
0
0
0
0
000000072,000072,000072,00000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,246
27,290
26,862
15,701
6,393
10,215
9,185
8,814
7,446
11,964
11,651
30,797
34,701
46,762
60,955
60,955
67,720
66,211
24,824
23,361
21,877
0
021,87723,36124,82466,21167,72060,95560,95546,76234,70130,79711,65111,9647,4468,8149,18510,2156,39315,70126,86227,29031,2460000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
309,894
313,722
310,170
247,073
253,512
262,743
263,479
271,373
742,907
290,478
305,565
318,721
320,421
334,004
346,855
356,162
372,303
373,348
385,559
395,452
416,972
406,386
705,077
703,323
713,611
719,049
728,888
737,600
742,670
747,294
753,616
763,198
771,620
776,471
780,813
781,923
790,275
793,347
779,439
775,556
793,389
795,473
801,073
809,029
1,351,142
1,649,056
1,707,095
1,750,839
1,792,340
1,921,631
2,003,157
2,462,408
2,305,945
2,354,019
2,438,794
2,394,171
2,416,691
2,454,441
2,467,822
2,526,157
2,616,494
2,679,359
2,681,434
2,714,472
3,049,995
3,116,804
3,160,366
3,248,071
3,344,286
3,455,754
3,495,445
3,646,128
3,767,987
3,922,658
4,002,943
4,203,773
4,390,675
4,607,779
4,657,746
4,866,466
5,060,005
5,212,112
4,992,418
5,179,832
5,511,878
5,751,482
5,762,564
6,012,838
6,222,729
6,222,7296,012,8385,762,5645,751,4825,511,8785,179,8324,992,4185,212,1125,060,0054,866,4664,657,7464,607,7794,390,6754,203,7734,002,9433,922,6583,767,9873,646,1283,495,4453,455,7543,344,2863,248,0713,160,3663,116,8043,049,9952,714,4722,681,4342,679,3592,616,4942,526,1572,467,8222,454,4412,416,6912,394,1712,438,7942,354,0192,305,9452,462,4082,003,1571,921,6311,792,3401,750,8391,707,0951,649,0561,351,142809,029801,073795,473793,389775,556779,439793,347790,275781,923780,813776,471771,620763,198753,616747,294742,670737,600728,888719,049713,611703,323705,077406,386416,972395,452385,559373,348372,303356,162346,855334,004320,421318,721305,565290,478742,907271,373263,479262,743253,512247,073310,170313,722309,894
   Common Stock
145,749
145,749
145,749
145,749
0
145,749
145,749
145,749
0
145,749
145,749
145,749
145,749
145,749
145,749
145,749
145,749
145,749
145,749
145,749
145,749
145,749
171,157
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
256,736
374,468
407,728
815,456
815,456
815,456
815,456
1,060,093
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,146,869
1,178,524
1,178,524
1,178,524
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
1,178,523
0
01,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5231,178,5241,178,5241,178,5241,146,8691,146,8691,146,8691,146,8691,146,8691,146,8691,146,8691,146,8691,146,8691,146,8691,146,8691,146,8691,146,8691,060,093815,456815,456815,456815,456407,728374,468256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736256,736171,157145,749145,749145,749145,749145,749145,749145,749145,749145,749145,749145,749145,749145,7490145,749145,749145,7490145,749145,749145,749145,749
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
858
-91
818
-125
-219
-147
-209
-206
-23
267
213
311
305
429
-99
-99
-941
-790
-496
-3,881
-3,886
0
0-3,886-3,881-496-790-941-99-99429305311213267-23-206-209-147-219-125818-918580000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue11,474,162
Cost of Revenue-8,529,455
Gross Profit2,944,7082,944,708
 
Operating Income (+$)
Gross Profit2,944,708
Operating Expense-10,231,530
Operating Income1,242,632-7,286,822
 
Operating Expense (+$)
Research Development624,870
Selling General Administrative735,992
Selling And Marketing Expenses0
Operating Expense10,231,5301,360,863
 
Net Interest Income (+$)
Interest Income113,471
Interest Expense-43,768
Other Finance Cost-3,463
Net Interest Income66,241
 
Pretax Income (+$)
Operating Income1,242,632
Net Interest Income66,241
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,204,6441,242,632
EBIT - interestExpense = -43,768
1,055,341
1,099,109
Interest Expense43,768
Earnings Before Interest and Taxes (EBIT)01,248,412
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,204,644
Tax Provision-149,337
Net Income From Continuing Ops1,055,3071,055,307
Net Income1,055,341
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-66,241
 

Technical Analysis of Apeloa
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Apeloa. The general trend of Apeloa is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Apeloa's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Apeloa Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.52 < 14.22 < 14.44.

The bearish price targets are: 12.32 > 12.23 > 10.66.

Tweet this
Apeloa Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Apeloa Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Apeloa Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Apeloa Pharmaceutical Co Ltd. The current macd is -0.11747382.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Apeloa price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Apeloa. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Apeloa price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Apeloa Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartApeloa Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Apeloa Pharmaceutical Co Ltd. The current adx is 13.36.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Apeloa shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Apeloa Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Apeloa Pharmaceutical Co Ltd. The current sar is 12.49.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Apeloa Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Apeloa Pharmaceutical Co Ltd. The current rsi is 47.02. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Apeloa Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartApeloa Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Apeloa Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Apeloa price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Apeloa Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartApeloa Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Apeloa Pharmaceutical Co Ltd. The current cci is 6.95127549.

Apeloa Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartApeloa Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Apeloa Pharmaceutical Co Ltd. The current cmo is -4.66251438.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Apeloa Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartApeloa Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Apeloa Pharmaceutical Co Ltd. The current willr is -51.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Apeloa is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Apeloa Pharmaceutical Co Ltd Daily Williams %R ChartApeloa Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Apeloa Pharmaceutical Co Ltd.

Apeloa Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Apeloa Pharmaceutical Co Ltd. The current atr is 0.4405128.

Apeloa Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartApeloa Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Apeloa Pharmaceutical Co Ltd. The current obv is 119,648,782.

Apeloa Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartApeloa Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Apeloa Pharmaceutical Co Ltd. The current mfi is 69.59.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Apeloa Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartApeloa Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Apeloa Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Apeloa Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Apeloa Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.017
Ma 20Greater thanMa 5012.895
Ma 50Greater thanMa 10013.168
Ma 100Greater thanMa 20014.151
OpenGreater thanClose12.870
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Apeloa with someone you think should read this too:
  • Are you bullish or bearish on Apeloa? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Apeloa? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Apeloa Pharmaceutical Co Ltd

I send you an email if I find something interesting about Apeloa Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Apeloa Pharmaceutical Co Ltd.

Receive notifications about Apeloa Pharmaceutical Co Ltd in your mailbox!